Genmab — April 2015
-
Pas nu på biotek er en farlig branche, alt kan gå galt ret hurtigt og lovene(dyre) forsøg kan pludselig ende i skraldespanden. Succes og fiasko måles nogle gange i femte decimal 0,00005, men optimismen fejler ikke noget:-) og ansøgningen må vel kunne laves allerede på 6 mdr. data siden Genmab kalkulerer herfor, men ved at vente kan det måske ende med at processen frem mod salg bliver kortere da tilladelsen kommer hurtigere og i mellemtiden har de måske planlagt selve produktionen og udrulningen?
-
-
Så kom det, vi alle ventede på http://www.godpaaske.dk/aprilsnar_2015.php
-
De styrer festen.
-
God påske.
-
Her fascinating speech entitled: Targeting Solid Cancers Using Antibody-Drug Conjugates against the Novel ADC Targets Tissue Factor and Axl will explore topics such as:
Tissue factor (TF) as a target for an antibody-drug conjugate
Preclinical efficacy of HuMax-TF-ADC in a broad range of solid cancer xenograft models
Imaging HuMax-TF-ADC in cynomolgus monkeys
Axl as a novel ADC target
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind